Lin M T, Chern S I
Am J Physiol. 1979 May;236(5):R302-6. doi: 10.1152/ajpregu.1979.236.5.R302.
The vasopressor and bradycardia responses to an intravenous dose of epinephrine were assessed in saline-controlled, 5-hydroxytryptamine-(5-HT) depleted, and 5-HT-potentiated rats. Regardless of the previous treatment epinephrine produced an insignificant change in the basal levels of mean arterial pressure and heart rate. However, brain serotonin alteration did produce some influences on the reflex bradycardia in response to an elevation in arterial pressure. Elevating 5-HT contents in brain with 5-hydroxytryptophan (5-HTP) after peripheral decarboxylase inhibition with Ro 4-4602 produced a significant reduction in reflex bradycardia compared to the controls. In contrast, depleting 5-HT contents in brain with either p-chlorophenylalanine (PCPA) or 5,7-dihydroxytryptamine (5,7-DHT) led to an enhancement of epinephrine-induced bradycardia. Moreover, the enhanced reflex bradycardia induced by PCPA treatment was readily blocked by the replacement of the depleted brain 5-HT with 5-HTP and Ro 4-4602. The results suggest that serotoninergic systems play a role in the elaboration or modulation of reflex bradycardia. Specifically, 5-HT appears to inhibit reflex bradycardia since its depletion facilitated and its elevation inhibited reflex bradycardia.
在生理盐水对照、5-羟色胺(5-HT)耗竭和5-HT增强的大鼠中,评估了静脉注射一剂肾上腺素后的升压和心动过缓反应。无论先前的治疗如何,肾上腺素对平均动脉压和心率的基础水平产生的变化均不显著。然而,脑5-羟色胺的改变确实对因动脉压升高引起的反射性心动过缓产生了一些影响。在用Ro 4-4602抑制外周脱羧酶后,用5-羟色氨酸(5-HTP)提高脑中5-HT含量,与对照组相比,反射性心动过缓显著降低。相反,用对氯苯丙氨酸(PCPA)或5,7-二羟色胺(5,7-DHT)耗竭脑中5-HT含量会导致肾上腺素诱导的心动过缓增强。此外,PCPA治疗诱导的增强的反射性心动过缓很容易被用5-HTP和Ro 4-4602替代耗尽的脑5-HT所阻断。结果表明,5-羟色胺能系统在反射性心动过缓的形成或调节中起作用。具体而言,5-HT似乎抑制反射性心动过缓,因为其耗竭促进而其升高抑制反射性心动过缓。